WallStreetZenWallStreetZen

NASDAQ: NRXP
Nrx Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Nrx Pharmaceuticals earnings were -$24.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest NRXP earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$5.5M, down 39.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NRXP reported annual earnings of -$25.1M, with -16.7% growth.

NRXP earnings history

Current Revenue
$0.0
Current Earnings
-$24.1M
Current Profit Margin
0%

NRXP Return on Equity

Current Company
N/A
Current Industry
-60.2%
Current Market
31.5%

NRXP undefined

Current Company
-460%
Current Industry
-2.5%
NRXP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NRXP announces earnings.

NRXP undefined

Current Company
95.82%
Current Industry
5.8%
NRXP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NRXP vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NRXP-$24.11M-$24.11MN/A-$2.01
SER-$235.00k-$939.00k-92.90%$0.01
ANL-$48.06M-$51.87MN/A-$1.62
ICCC$2.43M-$271.78kN/A-$0.05
TELO-$12.53M-$12.52MN/A-$0.42
View Top Biotech Stocks

Nrx Pharmaceuticals Earnings Reports & History FAQ

What were Nrx Pharmaceuticals's earnings last quarter?

Nrx Pharmaceuticals (NASDAQ: NRXP) reported Q1 2025 earnings per share (EPS) of -$0.34, up 54.05% year over year. Total NRXP earnings for the quarter were -$5.51 million. In the same quarter last year, Nrx Pharmaceuticals's earnings per share (EPS) was -$0.74.

If you're new to stock investing, here's how to buy Nrx Pharmaceuticals stock.

Is Nrx Pharmaceuticals profitable or losing money?

As of the last Nrx Pharmaceuticals earnings report, Nrx Pharmaceuticals is currently losing money. Nrx Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$24.11 million, a 5.96% decrease year over year.

What was NRXP's earnings growth in the past year?

As of Nrx Pharmaceuticals's earnings date in Q2 2025, Nrx Pharmaceuticals's earnings has grown year over year. NRXP earnings in the past year totalled -$24.11 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.